Characterization of currently marketed heparin products: reversed-phase ion-pairing liquid chromatography mass spectrometry of heparin digests.
about
Bottom-up low molecular weight heparin analysis using liquid chromatography-Fourier transform mass spectrometry for extensive characterizationCapillary electrophoresis for total glycosaminoglycan analysis.Identification of heparin samples that contain impurities or contaminants by chemometric pattern recognition analysis of proton NMR spectral data.Characterization of currently marketed heparin products: analysis of molecular weight and heparinase-I digest patterns.Ultra-performance ion-pairing liquid chromatography with on-line electrospray ion trap mass spectrometry for heparin disaccharide analysis.Disaccharide analysis of glycosaminoglycan mixtures by ultra-high-performance liquid chromatography-mass spectrometryExpanding the analytical toolbox for identity testing of pharmaceutical ingredients: Spectroscopic screening of dextrose using portable Raman and near infrared spectrometers.Screening enoxaparin tetrasaccharide SEC fractions for 3-O-sulfo-N-sulfoglucosamine residues using [(1)H,(15)N] HSQC NMR.Competitive inhibition of heparinase by persulfonated glycosaminoglycans: a tool to detect heparin contaminationThe US regulatory and pharmacopeia response to the global heparin contamination crisis.Analysis of glycosaminoglycan-derived, precolumn, 2-aminoacridone-labeled disaccharides with LC-fluorescence and LC-MS detection.Determination of Strong Acidic Drugs in Biological Matrices: A Review of Separation Methods
P2860
Q33847730-173E352D-C5C2-4083-9FF6-FAF23A195EC3Q33900448-1C8AFFB1-C7C1-4470-AFA2-D928E8FE45B1Q33934159-984FEFEF-CA51-4F2A-AB51-22DD940FA68BQ34013926-CEF848E9-A743-41DC-9C08-42A81C521A62Q35024451-865BBA2E-106C-483C-836F-7DF9F3C523F4Q35712855-59A2E0E6-ADEB-4F75-9577-B2E1F792AF8FQ35953270-183C469E-B9C1-49AB-855D-94F7F957798EQ38294362-96716440-A91F-439A-8FB3-B553CFA4B8C0Q41952349-5094A1E0-99C8-4E00-9DC0-8B673D9E87B6Q47421779-6BFB4361-DBF4-4C0F-9501-25BF586EDE88Q53625004-E35F53F5-B487-406E-B8FE-917E4464E13CQ59036809-3265E376-924B-4876-9DEB-A3DA9DA7A2A4
P2860
Characterization of currently marketed heparin products: reversed-phase ion-pairing liquid chromatography mass spectrometry of heparin digests.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Characterization of currently ...... ectrometry of heparin digests.
@en
Characterization of currently ...... ectrometry of heparin digests.
@nl
type
label
Characterization of currently ...... ectrometry of heparin digests.
@en
Characterization of currently ...... ectrometry of heparin digests.
@nl
prefLabel
Characterization of currently ...... ectrometry of heparin digests.
@en
Characterization of currently ...... ectrometry of heparin digests.
@nl
P2093
P356
P1433
P1476
Characterization of currently ...... pectrometry of heparin digests
@en
P2093
Adam M Brustkern
Ali Al-Hakim
Lucinda F Buhse
Moheb Nasr
P304
P356
10.1021/AC102301J
P407
P577
2010-11-11T00:00:00Z